Artificial intelligence-driven healthcare analytics startup iCarbonX is raising $106m for a series A round that values the company at $760m.
China-based healthcare analytics provider iCarbonX is looking at securing RMB700m ($106m) in series A capital from investors including biotechnology company Vcanbio Cell and Gene Engineering, China Money Network reported yesterday.
Vcanbio is providing RMB100m for the round that values iCarbonX at RMB5bn. Remaining backers have not been named.
Launched in October 2015, iCarbonX is developing a big data analytics platform that combines healthcare data with other information such as social and environmental data to gain a better insight into a…
